Piramal Enterprises Ltd
NSE:PEL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
864.0785
1 339.3
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Piramal Enterprises Ltd
Total Liabilities & Equity
Piramal Enterprises Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Piramal Enterprises Ltd
NSE:PEL
|
Total Liabilities & Equity
₹949.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
16%
|
|
|
Housing and Urban Development Corporation Ltd
NSE:HUDCO
|
Total Liabilities & Equity
₹1.3T
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
REC Limited
NSE:RECLTD
|
Total Liabilities & Equity
₹6.1T
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Power Finance Corporation Ltd
NSE:PFC
|
Total Liabilities & Equity
₹12.2T
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Indian Railway Finance Corp Ltd
NSE:IRFC
|
Total Liabilities & Equity
₹4.9T
|
CAGR 3-Years
3%
|
CAGR 5-Years
12%
|
CAGR 10-Years
19%
|
|
|
I
|
Indian Renewable Energy Development Agency Ltd
NSE:IREDA
|
Total Liabilities & Equity
₹797.3B
|
CAGR 3-Years
30%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Piramal Enterprises Ltd
Glance View
Piramal Enterprises Ltd. stands as a testament to strategic evolution within India's business landscape. Originating as a textile business in the 1980s, the company has undergone a dramatic transformation under the visionary leadership of Ajay Piramal. Transitioning from textiles, Piramal Enterprises repositioned itself in the healthcare sphere, marking significant milestones through strategic acquisitions. However, most notably, Piramal's foray into the healthcare and pharmaceutical industry leveraged both organic growth and targeted acquisitions, establishing it as a formidable player on the global stage. By focusing on high-quality and innovative solutions, Piramal offers products across a spectrum of sectors including critical care, healthcare insights, and analytics, all the while maintaining strong global partnerships which have amplified its reach and market presence. Diversification remains a cornerstone of Piramal's business model as it extends beyond its healthcare roots into the financial services realm. The company's financial services arm encompasses a variety of avenues such as lending, distressed asset investment, and real estate funding, illustrating its adeptness at identifying and capitalizing on market opportunities. By marrying robust governance with a keen understanding of market dynamics, Piramal Enterprises ingeniously leverages its strengths in both its primary markets. With a deliberate focus on achieving operational efficiency and strategic clarity, Piramal sustains its growth trajectory while ensuring long-term value creation for its stakeholders, showcasing resilience and adaptability in an ever-evolving economic environment.
See Also
What is Piramal Enterprises Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
949.4B
INR
Based on the financial report for Mar 31, 2025, Piramal Enterprises Ltd's Total Liabilities & Equity amounts to 949.4B INR.
What is Piramal Enterprises Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
16%
Over the last year, the Total Liabilities & Equity growth was 15%. The average annual Total Liabilities & Equity growth rates for Piramal Enterprises Ltd have been -2% over the past three years , 5% over the past five years , and 16% over the past ten years .